Findings and conclusions
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- GEC-ESTRO/ACROP recommendations for performing bladder-sparing treatment with brachytherapy for muscle-invasive bladder carcinoma.Radiother Oncol. 2017; 122: 340-346https://doi.org/10.1016/j.radonc.2016.12.022
- Organ preservation in invasive bladder cancer: brachytherapy, an alternative to cystectomy and combined modality treatment?.Int J Radiat Oncol Biol Phys. 2005; 61: 678-686https://doi.org/10.1016/j.ijrobp.2004.06.249
- Propensity score analysis of radical cystectomy versus bladder-sparing trimodal therapy in the setting of a multidisciplinary bladder cancer clinic.J Clin Oncol. 2017; 35: 2299-2305https://doi.org/10.1200/JCO.2016.69.2327
- Brachytherapy.Dev Ophthalmol. 2013; 52: 29-35https://doi.org/10.1159/000351053
- The use and effectiveness of cadaveric workshops in higher surgical training: a systematic review.Ann R Coll Surg Engl. 2011; 93: 347-352https://doi.org/10.1308/147870811X582954
- A reusable perfused human cadaver model for surgical training: an initial proof of concept study.Mil Med. 2019; 184: 43-47https://doi.org/10.1093/milmed/usy383
Publication stageIn Press Corrected Proof
Disclosures: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. The authors report no proprietary or commercial interest in any product mentioned or concept discussed in this article.